Table 5.
FCV-19S | SABAS | BSMAS | IGDS |
Group 1 | |||
High | −0.204 (0.140), P = 0.15 | −0.034 (0.095), P = 0.72 | 0.034 (0.063), P = 0.59 |
Low | −0.807 (0.128), P < 0.01** | −0.319 (0.081), P < 0.01** | −0.219 (0.063), P < 0.01** |
Group 2 | |||
High | −0.014 (0.126), P = 0.91 | 0.245 (0.098), P = 0.01* | 0.180 (0.089), P = 0.04* |
Low | −0.384 (0.116), P < 0.01** | 0.034 (0.086), P = 0.69 | −0.081 (0.067), P = 0.22 |
Group 3 | |||
High | 1.093 (0.422), P = 0.01* | –a | –a |
Low | 1.208 (0.289), P < 0.01** | –a | –a |
All participants | |||
High | 0.008 (0.092), P = 0.98 | 0.119 (0.071), P = 0.09 | 0.149 (0.059), P = 0.01* |
Low | −0.493 (0.083), P < 0.01** | −0.119 (0.063), P = 0.04* | −0.101 (0.048), P = 0.03* |
a Post-hoc slope tests were not performed due to the nonsignificant interaction effects (Please see Table 4).